Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Consortium Goes For Pure Pharmaceuticals

by Patricia Layman Short
November 10, 2008 | A version of this story appeared in Volume 86, Issue 45

Imperial College London is coordinating a four-year European Union project to purify active pharmaceutical ingredients by combining organic solvent nanofiltration with molecularly imprinted polymers in membrane formats. The project’s nine partners will appoint nine Ph.D. students and three postdoctoral fellows to undertake the work. Academic partners are Imperial College, Germany’s University of Dortmund, and Italy’s Institute for Membrane Technology. Technology providers MIP Technologies and Membrane Extraction Technology will work with four end-users—Hovione, UCB Pharma, GlaxoSmithKline, and Lonza.?

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.